169322 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors Interferon
Interferon-alpha induced genes
#302Anti-interferon-α antibodies
#303Anti-interferon-α antibodies
#304Interferon gamma-like protein
#305Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
#306Systemic lupus erythematosus
#307Set of ubiquitous cellular proteins involved in viral life cycle
#308Method for providing natural therapeutic agents with high therapeutic index
#309T-bet antibodies
#310Definitive diagnosis of EPM in the horse
#311Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
#312Interferon-like proteins and uses thereof
#313Monoclonal antibodies to type I interferon receptor
#314Screening method for identifying compounds that selectively induce interferon alpha
#315Methods for increasing production of IFN-gamma in natural killer cells expressing LLT1 receptor
#316Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma
#317Interferon-like molecules and uses thereof
#318Rational directed protein evolution using two-dimensional rational mutagenesis scanning
#319Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
#320Method of detecting antigen-specific T lymphocytes
#321Method of using physiological markers to estimate cardiovascular risk
#322Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
#323Compositions and methods for treatment of central nervous system (CNS) autoimmune associated diseases or disorders
#324Peptides for use in treatment and diagnosis of type 1 diabetes
#325Molecular diagnostic kits for evaluating stress